➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Medtronic
Boehringer Ingelheim
Merck

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEVOMILNACIPRAN HYDROCHLORIDE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Levomilnacipran Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00969150 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Completed Forest Laboratories Phase 3 2009-09-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder.
NCT00969709 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Completed Forest Laboratories Phase 3 2009-09-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major depressive disorder.
NCT01034462 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Completed Forest Laboratories Phase 3 2009-12-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Levomilnacipran Hydrochloride

Condition Name

Condition Name for Levomilnacipran Hydrochloride
Intervention Trials
Major Depressive Disorder 8
Tobacco Use Disorder 1
None (i.e. Healthy Volunteers) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Levomilnacipran Hydrochloride
Intervention Trials
Depressive Disorder, Major 10
Depressive Disorder 10
Depression 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Levomilnacipran Hydrochloride

Trials by Country

Trials by Country for Levomilnacipran Hydrochloride
Location Trials
United States 141
Canada 4
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Levomilnacipran Hydrochloride
Location Trials
New York 8
California 8
Illinois 8
Ohio 7
Florida 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Levomilnacipran Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Levomilnacipran Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Levomilnacipran Hydrochloride
Clinical Trial Phase Trials
Completed 5
Recruiting 4
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Levomilnacipran Hydrochloride

Sponsor Name

Sponsor Name for Levomilnacipran Hydrochloride
Sponsor Trials
Forest Laboratories 8
Allergan 2
Institute for Advanced Medical Research, Alpharetta, GA 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Levomilnacipran Hydrochloride
Sponsor Trials
Industry 10
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Harvard Business School
Baxter
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.